Akero Therapeutics Inc buy Morgan Stanley
Start price
28.01.25
/
50%
€49.44
Target price
28.01.26
€92.02
Performance (%)
-5.00%
End price
29.01.26
-
Summary
This prediction is currently being closed. With a performance of -5.00%, the BUY prediction for Akero Therapeutics Inc by Morgan_Stanley is down slightly. Morgan_Stanley has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | -6,02 % | -4,60 % | 1,27 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % | 14,57 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % | 28,11 % |
| iShares S&P 500 | -0,26 % | -0,84 % | 10,20 % |
Comments by Morgan_Stanley for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Morgan Stanley from $46.00 to $96.00. They now have an "overweight" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€38.28
10.03.25
10.03.25
-
10.03.26
10.03.26
22.70%
08.12.25
08.12.25
Stopped prediction by Morgan_Stanley for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€14.00
11.10.23
11.10.23
€31.05
11.10.24
11.10.24
92.86%
12.10.24
12.10.24